Literature DB >> 10233887

Activation of hematopoietic progenitor kinase-1 by erythropoietin.

Y Nagata1, F Kiefer, T Watanabe, K Todokoro.   

Abstract

Hematopoietic progenitor kinase-1 (HPK1), which is expressed predominantly in hematopoietic cells, was identified as a mammalian Ste20 homologue that, upon transfection, leads to activation of JNK/SAPK in nonhematopoietic cells. The JNK/SAPK pathway is activated by various environmental stresses and proinflammatory and hematopoietic cytokines. Upstream activators of HPK1 currently remain elusive, and its precise role in hematopoiesis has yet to be defined. We therefore examined the possible involvement of HPK1 in erythropoietin (Epo) and environmental stress-induced JNK/SAPK activation in the Epo-dependent FD-EPO cells and Epo-responsive SKT6 cells. We found that Epo, but not environmental stresses, induced rapid and transient activation of HPK1, whereas both induced activation of JNK/SAPK. A screen for HPK1 binding proteins identified the hematopoietic cell-specific protein 1 (HS1) as a potential HPK1 interaction partner. We found HPK1 constitutively associated with HS1 and that HS1 was tyrosine-phosphorylated in response to cellular stresses as well as Epo stimulation. Furthermore, antisense oligonucleotides to HPK1 suppressed Epo-dependent cell growth and Epo-induced erythroid differentiation. We therefore conclude that Epo induces activation of both HPK1 and HS1, whereas cellular stresses activate only HS1, and that the HPK1-JNK/SAPK pathway is involved in Epo-induced growth and differentiation signals.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10233887

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  8 in total

1.  Activation of hematopoietic progenitor kinase 1 involves relocation, autophosphorylation, and transphosphorylation by protein kinase D1.

Authors:  Rüdiger Arnold; Irene M Patzak; Brit Neuhaus; Sadia Vancauwenbergh; André Veillette; Johan Van Lint; Friedemann Kiefer
Journal:  Mol Cell Biol       Date:  2005-03       Impact factor: 4.272

2.  Haematopoietic lineage cell-specific protein 1 (HS1) promotes actin-related protein (Arp) 2/3 complex-mediated actin polymerization.

Authors:  Takehito Uruno; Peijun Zhang; Jiali Liu; Jian-Jiang Hao; Xi Zhan
Journal:  Biochem J       Date:  2003-04-15       Impact factor: 3.857

3.  Proteasome-mediated degradation and functions of hematopoietic progenitor kinase 1 in pancreatic cancer.

Authors:  Hua Wang; Xianzhou Song; Craig Logsdon; Guisheng Zhou; Douglas B Evans; James L Abbruzzese; Stanley R Hamilton; Tse-Hua Tan; Huamin Wang
Journal:  Cancer Res       Date:  2009-01-13       Impact factor: 12.701

4.  The CUL7/F-box and WD repeat domain containing 8 (CUL7/Fbxw8) ubiquitin ligase promotes degradation of hematopoietic progenitor kinase 1.

Authors:  Hua Wang; Yue Chen; Ping Lin; Lei Li; Guisheng Zhou; Guangchao Liu; Craig Logsdon; Jianping Jin; James L Abbruzzese; Tse-Hua Tan; Huamin Wang
Journal:  J Biol Chem       Date:  2013-12-20       Impact factor: 5.157

5.  HPK1 associates with SKAP-HOM to negatively regulate Rap1-mediated B-lymphocyte adhesion.

Authors:  Sebastian Königsberger; Doris Peckl-Schmid; Nadja Zaborsky; Irene Patzak; Friedemann Kiefer; Gernot Achatz
Journal:  PLoS One       Date:  2010-09-01       Impact factor: 3.240

6.  B cell adaptor containing src homology 2 domain (BASH) links B cell receptor signaling to the activation of hematopoietic progenitor kinase 1.

Authors:  S Tsuji; M Okamoto; K Yamada; N Okamoto; R Goitsuka; R Arnold; F Kiefer; D Kitamura
Journal:  J Exp Med       Date:  2001-08-20       Impact factor: 14.307

7.  Comparative genome analysis of cortactin and HS1: the significance of the F-actin binding repeat domain.

Authors:  Agnes G S H van Rossum; Ellen Schuuring-Scholtes; Vera van Buuren-van Seggelen; Philip M Kluin; Ed Schuuring
Journal:  BMC Genomics       Date:  2005-02-14       Impact factor: 3.969

Review 8.  A perspective on HPK1 as a novel immuno-oncology drug target.

Authors:  Sansana Sawasdikosol; Steven Burakoff
Journal:  Elife       Date:  2020-09-08       Impact factor: 8.140

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.